1. A Randomized Phase 2 Study Comparing the Combination of Ficlatuzumab and Gefitinib with Gefitinib Alone in Asian Patients with Advanced Stage Pulmonary Adenocarcinoma. Issue 10 (October 2016) Authors: Mok, Tony Shu Kam; Geater, Sarayut Lucien; Su, Wu‐Chou; Tan, Eng‐Huat; Yang, James Chi‐Hsin; Chang, Gee‐Chen; Han, May; Komarnitsky, Philip; Payumo, Francis; Garrus, Jennifer E.; Close, Sandra; Park, Keunchil Journal: Journal of thoracic oncology Issue: Volume 11:Issue 10(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Clinical activity of afatinib in patients with advanced non-small-cell lung cancer harbouring uncommon EGFR mutations: a combined post-hoc analysis of LUX-Lung 2, LUX-Lung 3, and LUX-Lung 6. Issue 7 (July 2015) Authors: Yang, James C-H; Sequist, Lecia V; Geater, Sarayut Lucien; Tsai, Chun-Ming; Mok, Tony Shu Kam; Schuler, Martin; Yamamoto, Nobuyuki; Yu, Chong-Jen; Ou, Sai-Hong I; Zhou, Caicun; Massey, Daniel; Zazulina, Victoria; Wu, Yi-Long Journal: Lancet oncology Issue: Volume 16:Issue 7(2015:Jul.) Page Start: 830 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗